ValiRx plc Working Capital to Net Assets Ratio
ValiRx plc working capital to net assets ratio. ValiRx plc (VAL) has a Working Capital to Net Assets ratio of 25.1% as of June 2025. Working capital of £757.13K (current assets of £844.58K minus current liabilities of £87.45K) is measured against net assets of £3.01 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ValiRx plc (VAL) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of ValiRx plc (2001–2024)
Working capital to net assets ratio of ValiRx plc from 2001 to 2024. This chart shows how ValiRx plc's Working Capital to Net Assets ratio has evolved across 25 annual periods from 2001 to 2024. As of June 2025, the ratio stands at 25.1%, reflecting working capital of £757.13K against net assets of £3.01 Million GBP. See VAL days of operational coverage to measure how many days the company can operate on defensive assets alone.
ValiRx plc Working Capital to Net Assets Ratio by Year (2001–2024)
ValiRx plc working capital to net assets ratio by year from 2001 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for ValiRx plc from 2001 to 2024, covering 25 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ValiRx plc asset portfolio.
| Year | WC/NA Ratio | Working Capital (GBP) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 39.6% | £1.55 Million | £3.92 Million | £1.90 Million | £345.02K | ▲ +27.5 pp |
| 2023 | 12.1% | £351.82K | £2.90 Million | £566.48K | £214.65K | ▼ -22.8 pp |
| 2022 | 34.9% | £1.34 Million | £3.83 Million | £1.46 Million | £127.58K | ▲ +13.5 pp |
| 2021 | 21.4% | £731.79K | £3.41 Million | £800.01K | £68.22K | ▼ -17.7 pp |
| 2020 | 39.1% | £1.86 Million | £4.76 Million | £1.98 Million | £124.48K | ▲ +84.1 pp |
| 2019 | -45.0% | £-999.63K | £2.22 Million | £381.87K | £1.38 Million | ▼ -38.5 pp |
| 2018 | -6.5% | £-195.53K | £3.03 Million | £1.01 Million | £1.20 Million | ▼ -13.6 pp |
| 2017 | 7.1% | £224.82K | £3.15 Million | £2.01 Million | £1.78 Million | ▲ +26.8 pp |
| 2016 | -19.7% | £-465.71K | £2.37 Million | £2.13 Million | £2.59 Million | ▼ -60.2 pp |
| 2015 | 40.5% | £1.84 Million | £4.53 Million | £2.43 Million | £588.55K | ▲ +26.0 pp |
| 2014 | 14.6% | £406.50K | £2.79 Million | £1.24 Million | £835.08K | ▼ -3.3 pp |
| 2013 | 17.9% | £578.64K | £3.23 Million | £1.45 Million | £876.10K | ▼ -28.9 pp |
| 2012 | 46.8% | £2.36 Million | £5.04 Million | £2.62 Million | £261.63K | ▲ +5.9 pp |
| 2011 | 40.8% | £1.81 Million | £4.42 Million | £1.95 Million | £141.00K | ▲ +19.9 pp |
| 2010 | 21.0% | £419.00K | £2.00 Million | £922.00K | £503.00K | ▲ +83.5 pp |
| 2009 | -62.5% | £-567.00K | £907.00K | £191.00K | £758.00K | ▼ -40.6 pp |
| 2008 | -21.9% | £-300.00K | £1.37 Million | £109.00K | £409.00K | ▼ -30.5 pp |
| 2007 | 8.7% | £145.00K | £1.67 Million | £241.00K | £96.00K | ▼ -23.3 pp |
| 2006 | 32.0% | £859.00K | £2.69 Million | £964.00K | £105.00K | ▼ -30.1 pp |
| 2006 | 62.1% | £100.00K | £161.00K | £109.00K | £9.00K | ▼ -37.9 pp |
| 2005 | 100.0% | £-203.00K | £-203.00K | £2.00K | £205.00K | ▲ +0.0 pp |
| 2004 | 100.0% | £-69.00K | £-69.00K | £21.00K | £90.00K | ▲ +0.0 pp |
| 2003 | 100.0% | £67.00K | £67.00K | £126.00K | £59.00K | ▲ +0.0 pp |
| 2002 | 100.0% | £-141.00K | £-141.00K | £202.00K | £343.00K | ▼ -11.8 pp |
| 2001 | 111.8% | £1.12 Million | £1.00 Million | £1.53 Million | £409.00K | — |